APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease

Related articles

1. FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?

   This article has 3 authors:

   1. Martin Higgins
   2. Veronica Wasef
   3. Andrea Kwakowsky

2. Association of circulating proteasome activity with Alzheimer’s pathology and cognitive functions in APOE ε4 carriers

   This article has 11 authors:

   1. Bon Gook Koo
   2. Ha-Eun Seo
   3. Yejin Yun
   4. Daegyeom Kim
   5. Jae Myeong Kang
   6. Jaelim Cho
   7. Sang-Yoon Lee
   8. Yu Joo Lee
   9. Kee Hyung Park
   10. Min Jae Lee
   11. Young Noh

3. Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients

   This article has 23 authors:

   1. Jonas Neher
   2. Ping Liu
   3. Ann-Christin Wendeln
   4. Jessica Wagner
   5. Fabian Brückner
   6. Jian Sun
   7. Xiaoqin Huang
   8. Thomas Lewis
   9. Lisa Steinbrecher
   10. Nina Hermann
   11. Xidi Yuan
   12. Yuanyuan Deng
   13. Angelos Skodras
   14. Natalie Beschorner
   15. Therese Klingstedt
   16. Katleen Wild
   17. Lisa Haesler
   18. Marius Lambert
   19. Simon Lindner
   20. Tammaryn Lashley
   21. Matthias Brendel
   22. Peter Nilsson
   23. Mathias Jucker